Imprimis Pharmaceuticals, Inc.
(NASDAQ : IMMY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.98%14.4214.2%$234.56m
SHPGShire PLC Sponsored ADR
1.88%143.500.4%$210.00m
PRGOPerrigo Co. Plc
1.41%78.676.4%$156.57m
MNKMallinckrodt Plc
2.80%37.1417.7%$121.20m
UTHRUnited Therapeutics Corporation
0.72%130.7413.9%$89.29m
JAZZJazz Pharmaceuticals Plc
2.57%146.282.2%$79.41m
ENDPEndo International Plc
-1.47%8.408.9%$71.87m
HZNPHorizon Pharma plc
-0.08%13.167.6%$66.82m
ALRAlere Inc.
0.28%49.582.7%$66.32m
PRXLPAREXEL International Corporation
0.06%87.727.9%$63.88m
ICPTIntercept Pharmaceuticals, Inc.
0.79%105.5022.1%$63.12m
MYOKMyoKardia, Inc.
3.47%44.753.0%$55.87m
NDRMNeuroDerm Ltd.
-0.07%38.633.6%$51.86m
PTLAPortola Pharmaceuticals, Inc.
0.04%55.588.9%$43.62m
ICLRICON Plc
1.86%107.264.2%$41.36m

Company Profile

Imprimis Pharmaceuticals, Inc. engages in the development, production, and dispensing of innovative proprietary compounded pharmaceuticals. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.